Where are Oncofertility and Fertility Preservation Treatments Heading in 2016?

References

• Woodruff TK . The Oncofertility Consortium – addressing fertility in young people with cancer. Nat. Rev. Clin. Oncol.7(8), 466–475 (2010).
   PubMed Web of Science ®Google Scholar
• Dursun P , DoğanNU, AyhanA. Oncofertility for gynecologic and non-gynecologic cancers: fertility sparing in young women of reproductive age. Crit. Rev. Oncol. Hematol.92(3), 258–267 (2014).
   PubMed Web of Science ®Google Scholar
• Loren AW , ManguPB, BeckLNet al. American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J. Clin. Oncol.31(19), 2500–2510 (2013).
   PubMed Web of Science ®Google Scholar
• Picton HM , WynsC, AndersonRAet al. ESHRE Task Force On Fertility Preservation In Severe Diseases. A European perspective on testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys. Hum. Reprod.30(11), 2463–2475 (2015).
   PubMed Web of Science ®Google Scholar
• Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil. Steril.99(1), 37–43 (2013).
   Google Scholar
• von Wolff M , MontagM, DittrichR, DenschlagD, NawrothF, LawrenzB. Fertility preservation in women – a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch. Gynecol. Obstet.284(2), 427–435 (2011).
   PubMed Web of Science ®Google Scholar
• Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil. Steril.101(5), 1237–1243 (2014).
   Google Scholar
• Cakmak H , RosenMP. Ovarian stimulation in cancer patients. Fertil. Steril.99(6), 1476–1484 (2013).
   PubMed Web of Science ®Google Scholar
• Engmann L , BenadivaC, HumaidanP. GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. Reprod. Biomed. Online32(3), 274–285 (2016).
   PubMed Web of Science ®Google Scholar
• Cakmak H , KatzA, CedarsMI, RosenMP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil. Steril.100(6), 1673–1680 (2013).
   PubMed Web of Science ®Google Scholar
• Wang N , WangY, ChenQet al. Luteal-phase ovarian stimulation versus conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study. Clin. Endocrinol. (Oxf.)84(5), 720–728 (2016).
   PubMed Web of Science ®Google Scholar
• Lambertini M , Del MastroL, PescioMCet al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med.14(1), 1 (2016).
   PubMed Web of Science ®Google Scholar
• Bastings L , BeerendonkCC, WestphalJRet al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum. Reprod. Update19(5), 483–506 (2013).
   PubMed Web of Science ®Google Scholar
• Rosendahl M , GreveT, AndersenCY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J. Assist. Reprod. Genet.30(1), 11–24 (2013).
   PubMed Web of Science ®Google Scholar
• Salama M , WoodruffTK. New advances in ovarian autotransplantation to restore fertility in cancer patients. Cancer Metastasis Rev.34(4), 807–822 (2015).
   PubMed Web of Science ®Google Scholar
• Donnez J , DolmansMM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J. Assist. Reprod. Genet.32(8), 1167–1170 (2015).
   PubMed Web of Science ®Google Scholar
• Keros V , XellaS, HultenbyKet al. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum. Reprod.24(7), 1670–1683 (2009).
   PubMed Web of Science ®Google Scholar
• Silber S , KagawaN, KuwayamaM, GosdenR. Duration of fertility after fresh and frozen ovary transplantation. Fertil. Steril.94(6), 2191–2196 (2010).
   PubMed Web of Science ®Google Scholar
• Donnez J , DolmansMM, PellicerAet al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil. Steril.99(6), 1503–1513 (2013).
   PubMed Web of Science ®Google Scholar
• Amorim CA , CurabaM, Van LangendoncktA, DolmansMM, DonnezJ. Vitrification as an alternative means of cryopreserving ovarian tissue. Reprod. Biomed. Online23(2), 160–186 (2011).
   PubMed Web of Science ®Google Scholar
• Suzuki N , HashimotoS, IgarashiSet al. Assessment of long-term function of heterotopic transplants of vitrified ovarian tissue in cynomolgus monkeys. Hum. Reprod.27(8), 2420–2429 (2012).
   PubMed Web of Science ®Google Scholar
• Stern CJ , GookD, HaleLGet al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum. Reprod.28(11), 2996–2999 (2013).
   PubMed Web of Science ®Google Scholar
• Moore HC , UngerJM, PhillipsKAet al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N. Engl. J. Med.372(10), 923–932 (2015).
   PubMed Web of Science ®Google Scholar
• Lambertini M , BoniL, MichelottiAet al. Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial. JAMA314(24), 2632–2640 (2015).
   PubMed Web of Science ®Google Scholar
• Lambertini M , CeppiM, PoggioFet al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann. Oncol.26(12), 2408–2419 (2015).
   PubMed Web of Science ®Google Scholar
• Demeestere I , BriceP, PeccatoriFAet al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1 year follow-up of a prospective randomized trial. J. Clin. Oncol.31(7), 903–909 (2013).
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z , ZurH, DannEJ. Gonadotropin-releasing hormone agonist cotreatment during chemotherapy may increase pregnancy rate in survivors. Oncologist20(11), 1283–1289 (2015).
   PubMed Web of Science ®Google Scholar
• Martinez A , PoilblancM, FerronG, De CuypereM, JouveE, QuerleuD. Fertility-preserving surgical procedures, techniques. Best Pract. Res. Clin. Obstet. Gynaecol.26(3), 407–424 (2012).
   PubMed Web of Science ®Google Scholar
• Kanda Y , WadaH, YamasakiRet al. Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation. Ann. Hematol.93(2), 287–292 (2014).
   PubMed Web of Science ®Google Scholar
• Socie G , SaloojaN, CohenAet al. Late Effects Working Party of the European Study Group for Blood and Marrow Transplantation. Nonmalignant late effects after allogeneic stem cell transplantation. Blood101(9), 3373–3385 (2003).
   PubMed Web of Science ®Google Scholar
• Ataman LM , RodriguesJK, MarinhoRMet al. Creating a global community of practice for oncofertility. J. Global Oncol.2(2), 83–96 (2016).
   PubMedGoogle Scholar
• Frydman R , GrynbergM. Introduction: male fertility preservation: innovations and questions. Fertil. Steril.105(2), 247–248 (2016).
   PubMed Web of Science ®Google Scholar
• Yokonishi T , OgawaT. Cryopreservation of testis tissues and in vitro spermatogenesis. Reprod. Med. Biol.15, 21–28 (2016).
   PubMedGoogle Scholar
• Jahnukainen K , EhmckeJ, NurmioM, SchlattS. Autologous ectopic grafting of cryopreserved testicular tissue preserves the fertility of prepubescent monkeys that receive sterilizing cytotoxic therapy. Cancer Res.72(20), 5174–5178 (2012).
   PubMed Web of Science ®Google Scholar
• Wu X , GoodyearSM, AbramowitzLKet al. Fertile offspring derived from mouse spermatogonial stem cells cryopreserved for more than 14 years. Hum. Reprod.27(5), 1249–1259 (2012).
   PubMed Web of Science ®Google Scholar
• Hermann BP , SukhwaniM, WinklerFet al. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell.11(5), 715–726 (2012).
   PubMed Web of Science ®Google Scholar
• Yokonishi T , SatoT, KomeyaMet al. Offspring production with sperm grown in vitro from cryopreserved testis tissues. Nat. Commun.5, 4320 (2014).
   PubMed Web of Science ®Google Scholar
• Komeya M , KimuraH, NakamuraHet al. Long-term ex vivo maintenance of testis tissues producing fertile sperm in a microfluidic device. Sci. Rep.6, 21472 (2016).
   PubMed Web of Science ®Google Scholar
• Gies I , De SchepperJ, TournayeH. Progress and prospects for fertility preservation in prepubertal boys with cancer. Curr. Opin. Endocrinol. Diabetes Obes.22(3), 203–208 (2015).
   PubMedGoogle Scholar
• Faure A , BoutyA, O’BrienM, ThorupJ, HutsonJ, HelouryY. Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure?Nat. Rev. Urol.13(3), 141–150 (2016).
   PubMed Web of Science ®Google Scholar
• Sadri-Ardekani H , McLeanTW, KoganSet al. Experimental testicular tissue banking to generate spermatogenesis in the future: a multidisciplinary team approach. Methods15(99), 20–127 (2016).
   Google Scholar
• Sharma GT , DubeyPK, MeurSK. Survival and developmental competence of buffalo preantral follicles using three-dimensional collagen gel culture system. Anim. Reprod. Sci.114(1–3), 115–124 (2009).
   PubMed Web of Science ®Google Scholar
• Shikanov A , XuM, WoodruffTK, SheaLD. Interpenetrating fibrin-alginate matrices for in vitro ovarian follicle development. Biomaterials30(29), 5476–5485 (2009).
   PubMed Web of Science ®Google Scholar
• Xu M , West-FarrellER, StoufferRL, SheaLD, WoodruffTK, ZelinskiMB. Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles. Biol. Reprod.81(3), 587–594 (2009).
   PubMed Web of Science ®Google Scholar
• Xu M , FazleabasAT, ShikanovAet al. In vitro oocyte maturation and preantral follicle culture from the luteal-phase baboon ovary produce mature oocytes. Biol. Reprod.84(4), 689–697 (2011).
   PubMed Web of Science ®Google Scholar
• Xu J , LawsonMS, YeomanRRet al. Secondary follicle growth and oocyte maturation during encapsulated three-dimensional culture in rhesus monkeys: effects of gonadotrophins, oxygen and fetuin. Hum. Reprod.26(5), 1061–1072 (2011).
   PubMed Web of Science ®Google Scholar
• Xu M , BarrettSL, West-FarrellEet al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum. Reprod.24(10), 2531–2540 (2009).
   PubMed Web of Science ®Google Scholar
• Shea LD , WoodruffTK, ShikanovA. Bioengineering the ovarian follicle microenvironment. Annu. Rev. Biomed. Eng.16, 29–52 (2014).
   PubMed Web of Science ®Google Scholar
• Telfer EE , McLaughlinM. Strategies to support human oocyte development in vitro. Int. J. Dev. Biol.56(10–12), 901–907 (2012).
   PubMed Web of Science ®Google Scholar
• Higuchi CM , MaedaY, HoriuchiT, YamazakiY. A simplified method for three-dimensional (3-D) ovarian tissue culture yielding oocytes competent to produce full-term offspring in mice. PLoS ONE10, e0143114 (2015).
   PubMed Web of Science ®Google Scholar
• Hornick JE , DuncanFE, SheaLD, WoodruffTK. Isolated primate primordial follicles require a rigid physical environment to survive and grow in vitro. Hum. Reprod.27(6), 1801–1810 (2012).
   PubMed Web of Science ®Google Scholar
• Laronda MM , DuncanFE, HornickJEet al. Alginate encapsulation supports the growth and differentiation of human primordial follicles within ovarian cortical tissue. J. Assist. Reprod. Genet.31(8), 1013–1028 (2014).
   PubMed Web of Science ®Google Scholar
• Xiao S , ZhangJ, RomeroMM, SmithKN, SheaLD, WoodruffTK. In vitro follicle growth supports human oocyte meiotic maturation. Sci. Rep.5, 17323 (2015).
   PubMed Web of Science ®Google Scholar
• Kniazeva E , HardyAN, BoukaidiSA, WoodruffTK, JerussJS, SheaLD. Primordial follicle transplantation within designer biomaterial grafts produce live births in a mouse infertility model. Sci. Rep.5, 17709 (2015).
   PubMed Web of Science ®Google Scholar
• Anckaert E , De RyckeM, SmitzJ. Culture of oocytes and risk of imprinting defects. Hum. Reprod. Update19(1), 52–66 (2013).
   PubMed Web of Science ®Google Scholar
• Saenz-de-Juano MD , BillooyeK, SmitzJ, AnckaertE. The loss of imprinted DNA methylation in mouse blastocysts is inflicted to a similar extent by in vitro follicle culture and ovulation induction. Mol. Hum. Reprod.22(6), 427–441 (2016).
   PubMed Web of Science ®Google Scholar
• Hayashi K , OhtaH, KurimotoK, AramakiS, SaitouM. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell146(4), 519–532 (2011).
   PubMed Web of Science ®Google Scholar
• Hayashi K , OgushiS, KurimotoK, ShimamotoS, OhtaH, SaitouM. Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science338(6109), 971–975 (2012).
   PubMed Web of Science ®Google Scholar
• Hayashi K , SaitouM. Generation of eggs from mouse embryonic stem cells and induced pluripotent stem cells. Nat. Protoc.8(8), 1513–1524 (2013).
   PubMed Web of Science ®Google Scholar
• Roness H , KashiO, MeirowD. Prevention of chemotherapy-induced ovarian damage. Fertil. Steril.105(1), 20–29 (2016).
   PubMed Web of Science ®Google Scholar
• Meng Y , XuZ, WuFet al. Sphingosine-1-phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice. Fertil. Steril.102(3), 871–877 (2014).
   PubMed Web of Science ®Google Scholar
• Li F , TuranV, LiermanS, CuvelierC, De SutterP, OktayK. Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death. Hum. Reprod.29(1), 107–113 (2014).
   PubMed Web of Science ®Google Scholar
• Hancke K , StrauchO, KisselC, GobelH, SchaferW, DenschlagD. Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil. Steril.87(1), 172–177 (2007).
   PubMed Web of Science ®Google Scholar
• Morita Y , PerezGI, ParisFet al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med.6(10), 1109–1114 (2000).
   PubMed Web of Science ®Google Scholar
• Kaya H , DesdiciogluR, SezikMet al. Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model? Fertil. Steril. 89(3), 732–735 (2008).
   PubMed Web of Science ®Google Scholar
• Zelinski MB , MurphyMK, LawsonMSet al. In vivo delivery of FTY720 prevents radiation-induced ovarian failure and infertility in adult female nonhuman primates. Fertil. Steril.95(4), 1440–1445 (2011).
   PubMed Web of Science ®Google Scholar
• Roness H , Kalich-PhilosophL, MeirowD. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents. Hum. Reprod. Update20(5), 759–774 (2014).
   PubMed Web of Science ®Google Scholar
• Gonfloni S , Di TellaL, CaldarolaSet al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat. Med.15(10), 1179–1185 (2009).
   PubMed Web of Science ®Google Scholar
• Kim SY , CordeiroMH, SernaVAet al. Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network. Cell Death Differ.20(8), 987–997 (2013).
   PubMed Web of Science ®Google Scholar
• Kalich-Philosoph L , RonessH, CarmelyAet al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci. Transl. Med.5(185), 185ra162 (2013).
   Web of Science ®Google Scholar
• Li J , KawamuraK, ChengYet al. Activation of dormant ovarian follicles to generate mature eggs. Proc. Natl Acad. Sci. USA107(22), 10280–10284 (2010).
   PubMed Web of Science ®Google Scholar
• Kawamura K , ChengY, SuzukiNet al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc. Natl Acad. Sci. USA110(43), 17474–17479 (2013).
   PubMed Web of Science ®Google Scholar
• Halpert G , SredniB. The effect of the novel tellurium compound AS101 on autoimmune diseases. Autoimmun. Rev.13(12), 1230–1235 (2014).
   PubMed Web of Science ®Google Scholar
• Jain KK . Current status and future prospects of drug delivery systems. Methods Mol. Biol.1141, 1–56 (2014).
   PubMedGoogle Scholar
• Tahover E , PatilYP, GabizonAA. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes. Anticancer Drugs26(3), 241–258 (2015).
   PubMed Web of Science ®Google Scholar
• Ahn RW , BarrettSL, RajaMRet al. Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo. PLoS ONE8, e58491 (2013).
   PubMed Web of Science ®Google Scholar
• Johannesson L , JarvholmS. Uterus transplantation: current progress and future prospects. Int. J. Womens Health8, 43–51 (2016).
   PubMed Web of Science ®Google Scholar
• Kisu I , BannoK, MiharaM, SuganumaN, AokiD. Current status of uterus transplantation in primates and issues for clinical application. Fertil. Steril.100(1), 280–294 (2013).
   PubMed Web of Science ®Google Scholar
• Vajdic CM , van LeeuwenMT. Cancer incidence and risk factors after solid organ transplantation. Int. J. Cancer125(8), 1747–1754 (2009).
   PubMed Web of Science ®Google Scholar
• Fournier EM . Oncofertility and the rights to future fertility. JAMA Oncol.2(2), 249–252 (2016).
   PubMed Web of Science ®Google Scholar